Viewing Study NCT06656494


Ignite Creation Date: 2025-12-25 @ 1:46 AM
Ignite Modification Date: 2025-12-26 @ 12:04 AM
Study NCT ID: NCT06656494
Status: RECRUITING
Last Update Posted: 2025-07-08
First Post: 2024-10-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module